PragyaBGuptaMD,FRCS (Edin), DABPM, FAPCR(He/Him)

[Pronunciation: Pragya]

Anesthesiology • Escondido, CA

Addiction Medicine, Pain Medicine

Physician

Join to view full profile

Dr. Gupta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gupta's full profile

Already have an account?

Office
1955 Citracado Pkwy
Ste 203
Escondido, CA 92029
Phone+1 760-738-5533

Fax+1 760-738-3835

Summary

I am a board-certified Anesthesiologist and Interventional Pain Management Specialist, a Fellow of the Academy of Physicians in Clinical Research, a Certified Principal Investigator, and a Fellow of Surgeons of the Royal College of Edinburgh.

Education & Training

Tufts Medical CenterFellowship, Pain Medicine (Anesthesiology), 1998 - 1999
Tufts Medical CenterResidency, Anesthesiology, 1995 - 1998
Ascension Illinois/Saint FrancisInternship, Transitional Year, 1994 - 1995
RG Kar Medical College CalcuttaClass of 1985

Certifications & Licensure

MA State Medical License 1997 - 2026
CA State Medical License 2017 - 2025
KY State Medical License 1999 - 2025
American Board of Anesthesiology Anesthesiology
American Board of Anesthesiology Pain Medicine

Awards, Honors, & Recognition

Fellow of the Royal College of Surgeons of Edinburgh Royal College of Surgeons of Edinburgh, UK, 1993
CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2012
CMS Meaningful Use Stage 1 Certification PrognoCIS EHR, Bizmatics, 2011

Clinical Trials

A Study of the Pharmacokinetics, Safety, and Preliminary Efficacy of MDT-15 in Subjects With Lumbosacral Radiculopathy Start of enrollment: 2013 Jul 01
Completed
Phase 2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder Start of enrollment: 2021 Jun 30
Completed
Not Applicable
Clinical Trial to Assess Safety of SI-6603 in Patients With Lumbar Disc Herniation Start of enrollment: 2007 Dec 01
Completed
Phase 2
Placebo-controlled Study to Evaluate Rexlemestrocel-L Alone or Combined With Hyaluronic Acid in Participants With Chronic Low Back Pain Start of enrollment: 2015 Mar 06
Completed
Phase 3
Study to Evaluate Intra-articular Resiniferatoxin to Treat Moderate to Severe Pain From Knee Osteoarthritis Start of enrollment: 2021 Nov 15
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

1 citations
A phase 3, randomized, double-blind, sham-controlled trial of SI-6603 (condoliase) in patients with radicular leg pain associated with lumbar disc herniation.
Kee D Kim, Farshad Ahadian, Hamid Hassanzadeh, Jose Rivera, Kenneth Candido
The Spine Journal. 2024-12-01
20 citations
Spontaneous rupture of the spleen secondary to metastatic carcinoma
P. B. Gupta, L. Harvey
The British Journal of Surgery. 2005-12-06

Professional Memberships

American Academy of Pain Medicine - AAPM
Member
Spina Intervention Society
Member
American Association of Regional Anesthesia
Member
American Neuromodulation Society
Member
American Academy of Physician in Clinical Research
Member